aztreonam has been researched along with Meningitis, Meningococcal, Serogroup A in 2 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Isani, Z | 1 |
Rehman, N | 1 |
Adil, N | 1 |
el Messidi, M | 1 |
Greenman, RL | 1 |
Arcey, SM | 1 |
Dickinson, GM | 1 |
Mokhbat, JE | 1 |
Sabath, LD | 1 |
Platt, TB | 1 |
Friedhoff, LT | 1 |
2 other studies available for aztreonam and Meningitis, Meningococcal, Serogroup A
Article | Year |
---|---|
Aztreonam in the treatment of gram-negative meningitis in children.
Topics: Anti-Bacterial Agents; Aztreonam; Child, Preschool; Escherichia coli Infections; Gram-Negative Bacte | 1987 |
Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Female; Humans; Male; Meningitis; Meningitis, Meningo | 1985 |